Litcius/Paper detail

Genomic epidemiology and ceftazidime-avibactam high-level resistance mechanisms of <i>Pseudomonas aeruginosa</i> in China from 2010 to 2022

Xi Li, Longjie Zhou, Tailong Lei, Xiaofan Zhang, Jiayao Yao, Jintao He, Haiyang Liu, Heng Cai, Jingshu Ji, Yiwei Zhu, Yuexing Tu, Yunsong Yu, Hua Zhou

2024Emerging Microbes & Infections13 citationsDOIOpen Access PDF

Abstract

Ceftazidime-avibactam (CZA) resistance is a huge threat in the clinic; however, the underlying mechanism responsible for high-level CZA resistance in Pseudomonas aeruginosa (PA) isolates remains unknown. In this study, a total of 5,763 P. aeruginosa isolates were collected from 2010 to 2022 to investigate the ceftazidime-avibactam (CZA) high-level resistance mechanisms of Pseudomonas aeruginosa (PA) isolates in China. Fifty-six PER-producing isolates were identified, including 50 isolates carrying blaPER-1 in PA, and 6 isolates carrying blaPER-4. Of these, 82.1% (46/56) were classified as DTR-PA isolates, and 76.79% (43/56) were resistant to CZA. Importantly, blaPER-1 and blaPER-4 overexpression led to 16-fold and >1024-fold increases in the MICs of CZA, respectively. WGS revealed that the blaPER-1 gene was located in two different transferable IncP-2-type plasmids and chromosomes, whereas blaPER-4 was found only on chromosomes and was carried by a class 1 integron embedded in a Tn6485-like transposon. Overexpression of efflux pumps may be associated with high-level CZA resistance in blaPER-1-positive strains. Kinetic parameter analysis revealed that PER-4 exhibited a similar kcat/Km with ceftazidime and a high (∼3359-fold) IC50 value with avibactam compared to PER-1. Our study found that overexpression of PER-1 combined with enhanced efflux pump expression and the low affinity of PER-4 for avibactam contributes to high-level resistance to CZA. Additionally, the Tn6485-like transposon plays a significant role in disseminating blaPER. Urgent active surveillance is required to prevent the further spread of high-level CZA resistance in DTR-PA isolates.

Topics & Concepts

Ceftazidime/avibactamPseudomonas aeruginosaEpidemiologyCeftazidimeAvibactamMicrobiologyBiologyAntibiotic resistanceChinaMedicineGeneticsEnvironmental healthBacteriaAntibioticsInternal medicineGeographyArchaeologyAntibiotic Resistance in BacteriaBacteriophages and microbial interactionsBacterial biofilms and quorum sensing
Genomic epidemiology and ceftazidime-avibactam high-level resistance mechanisms of <i>Pseudomonas aeruginosa</i> in China from 2010 to 2022 | Litcius